GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LHC Group Inc (NAS:LHCG) » Definitions » EBIT

LHC Group (LHC Group) EBIT : $109 Mil (TTM As of Dec. 2022)


View and export this data going back to 2005. Start your Free Trial

What is LHC Group EBIT?

LHC Group's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2022 was $10 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2022 was $109 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. LHC Group's annualized ROC % for the quarter that ended in Dec. 2022 was 2.41%. LHC Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was 10.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. LHC Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was 1.77%.


LHC Group EBIT Historical Data

The historical data trend for LHC Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LHC Group EBIT Chart

LHC Group Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111.00 151.61 178.11 185.64 108.52

LHC Group Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.15 35.52 25.03 38.03 9.94

Competitive Comparison of LHC Group's EBIT

For the Medical Care Facilities subindustry, LHC Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LHC Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LHC Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LHC Group's EV-to-EBIT falls into.



LHC Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $109 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LHC Group  (NAS:LHCG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

LHC Group's annualized ROC % for the quarter that ended in Dec. 2022 is calculated as:

ROC % (Q: Dec. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2022 ) + Invested Capital (Q: Dec. 2022 ))/ count )
=66.664 * ( 1 - 3.05% )/( (2707.973 + 2662.385)/ 2 )
=64.630748/2685.179
=2.41 %

where

Invested Capital(Q: Sep. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2914.154 - 195.659 - ( 10.522 - max(0, 303.021 - 440.381+10.522))
=2707.973

Invested Capital(Q: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2896.957 - 216.661 - ( 17.911 - max(0, 290.454 - 408.179+17.911))
=2662.385

Note: The Operating Income data used here is four times the quarterly (Dec. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

LHC Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2022  Q: Dec. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=39.768/( ( (262.781 + max(133.619, 0)) + (262.276 + max(122.753, 0)) )/ 2 )
=39.768/( ( 396.4 + 385.029 )/ 2 )
=39.768/390.7145
=10.18 %

where Working Capital is:

Working Capital(Q: Sep. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(331.524 + 0 + 68.118) - (195.659 + 31.63 + 38.734)
=133.619

Working Capital(Q: Dec. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(313.163 + 0 + 63.599) - (216.661 + 0 + 37.348)
=122.753

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

LHC Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2022 )
=108.52/6115.409
=1.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LHC Group EBIT Related Terms

Thank you for viewing the detailed overview of LHC Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


LHC Group (LHC Group) Business Description

Traded in Other Exchanges
N/A
Address
901 Hugh Wallis Road South, Lafayette, LA, USA, 70508
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies, and long-term acute care hospitals. The company's home health service locations offer a wide range of services, including skilled nursing, medically-oriented social services and physical, occupational, and speech therapy. Its hospices provide end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors, and volunteers. Its other service segments are Home and community based, Facility-based, Hospice and Healthcare Innovations. The company derives most of its revenues from the Home health services.
Executives
Nicholas Iii Gachassin officer: EVP, General Counsel 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
Dale Mackel other: CFO 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508-2511
Reed W Earl Iii director 9510 OMSBY SLATION ROAD, STE 300, LOIISVILLE KY 40223
Kimberly S Seymour other: SVP, Chief Accounting Officer 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Tricia Nguyen other: EVP, Chief Medical Officer 1801 KIRA COURT, ARLINGTON TX 76006
Mcquiddy Collin other: SVP, Chief Accounting Officer 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Donald Dwayne Stelly officer: Senior Vice President 420 WEST PINHOOK ROAD, SUITE A, LAFAYETTE LA 70503
John L Indest director, officer: COO of Home, Senior V.P. 420 WEST PINHOOK ROAD, SUITE A, LAFAYETTE LA 70503
Ronald T Nixon director 1375 ENCLAVE PKWY, HOUSTON TX 77077
Keith G Myers director, 10 percent owner, officer: CEO and President 901 HUGH WALLIS RD S, LAFAYETTE LA 70508
Joshua L. Proffitt officer: Executive Vice President 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
Teri G. Fontenot director 18933 EAST PINNACLE CIRCLE, BATON ROUGE LA 70634
Tyree G Wilburn director
Jeff Reibel officer: See Remarks 9510 ORMSBY STATION ROAD, SUITE 300, LOUISVILLE KY 40223
Bruce D Greenstein officer: Chief Innovation Officer 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508